Abstract
The history and results of the National Acute Spinal Cord Injury Studies (NASCIS) are briefly reviewed. The current status of pharmacological therapy for acute spinal cord injury and future prospects are also summarized.
Similar content being viewed by others
Article PDF
References
Demopoulos H G, Milvy P, Kakari S, Ransohoff J (1972). Molecular aspects of membrane structure in cerebral edema. In: Reulen HJ, Schurmann K, eds. Steroids and Brain Edema. Springer-Verlag, New York.
Hall E D (1992). The neuroprotective pharmacology of methylprednisolone: a review. J Neurosurg 76: 13–22.
Bracken M B, Collins W F, Freeman, D F et al (1984). Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251: 45–52.
Bracken M B, Shepard M J, Hellenbrand K G, et al (1985). Methylprednisolone and neurologic function one year after injury: results of the national acute spinal cord injury study. J Neurosurg 63: 704–713.
Hall E D, Braughler J M (1982). Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 18: 320–327.
Faden A l, Jacobs T P, Holaday J W (1981). Opiate antagonist improves neurologic recovery after spinal cord injury. Science 211: 493–494.
Bracken M B, Shepard M J, Collins W F, et al (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: results of the second national acute spinal cord injury study. N Engl J Med 322: 1405–1411.
Bracken M B, Shepard M J, Collins W F, et al (1992). Methylprednisolone or naloxone in the treatment of acute spinal cord injury: one year follow-up results of the second national acute spinal cord injury study. J Neurosurg 76: 23–31.
Hall E D (1990) Steroids and neuronal destruction or stabilization. In: Simmonds H, ed. Steroids and Neuronal Activity. CIBA Foundation Symposium No. 153. Wiley and Sons, Chichester.
Hsu C Y, Dimitrijevic M R (1990). Methylprednisolone in spinal cord injury: the possible mechanism of action. J Neurotrauma 7: 115–119.
Bracken M B, Collins W F (1985) Randomized clinical trials of spinal cord injury treatment. In: Becker DP, Povlishock JT, eds. Central Nervous System Trauma Status Report, 1985. National Institute of Neurological and Communicative Disorders and Stroke, Washington, DC.
Hall E D, McCall J M, Chase R L, Yonkers P A, Braughler J M (1987). A non-glucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp 242: 137–142.
Geisler F, Dorsey F C, Coleman W P (1991). Recovery of motor function after spinal cord injury—a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med 324: 1829–1838.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bracken, M. Pharmacological treatment of acute spinal cord injury: current status and future prospects. Spinal Cord 30, 102–107 (1992). https://doi.org/10.1038/sc.1992.34
Issue Date:
DOI: https://doi.org/10.1038/sc.1992.34
Keywords
This article is cited by
-
Recent advances in the pharmacologic treatment of spinal cord injury
Metabolic Brain Disease (2015)
-
Klinische Erfahrungen und Ergebnisse der hochdosierten Methylprednisolontherapie bei Rückenmarkstrauma von 1991 bis 1993
Unfallchirurgie (1995)